The $425 million deal gives Merck access to a promising therapy for treating seriously ill COVID-19 patients.
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
Versum shareholders are scheduled to vote next month on a merger with Entegris that is valued at less than Merck's $5.9 billion proposal.
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
The $4 billion acquisition of Merck's consumer healthcare unit comes amid investor pressure on P&G to increase sales.
The damage inflicted in this year’s ransomware attacks will force corporations to review their IT resilience.
Why corporations sometimes can’t get the coverage they really need.
Companies are clamoring for the data and information they need to manage their exposures.
The acquisition of Afferent Pharmaceuticals gives Merck access to a drug candidate for treating neurogenic conditions including chronic cough.
He allegedly helped a friend make more than $700,000 on insider M&A info.
Merck, AlixPartners, Laboratory Corp. of America, Catamaran, Bell and Howell, Cyan, RealPage, WPX Energy
